Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
800 participants
INTERVENTIONAL
2025-06-01
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Deployment and Validation of Rho
NCT05245851
Immunophenotyping in Patients With Osteoporosis
NCT05132348
Osteoporotic Precisely Screening Using Chest Radiograph and Artificial Neural Network (OPSCAN)
NCT05721157
Assessment of Cortical Bone Mechanics Technology (CBMT) Fracture Discrimination Capability
NCT05721898
Chronic Obstructive Pulmonary Disease (COPD) and Osteoporosis
NCT01067248
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study team will identify applicable patient records from medical record review, and Radius will de-identify the x-ray images. The de-identified images will be run through the Rho AI program to identify osteoporosis or osteopenia, and a report will be generated to summarize the program's findings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Detection of Osteoporosis
Rho AI software
Rho is a AI enabled opportunistic pre-screening computer-aided detection and notification software for low bone mineral density.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rho AI software
Rho is a AI enabled opportunistic pre-screening computer-aided detection and notification software for low bone mineral density.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* images from people who have undergone spine fusion
Exclusion Criteria
50 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Bernatz, MD
Role: PRINCIPAL_INVESTIGATOR
UW School of Medicine and Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UW School of Medicine and Public Health
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A536100
Identifier Type: OTHER
Identifier Source: secondary_id
Protocol Version
Identifier Type: OTHER
Identifier Source: secondary_id
2024-1832
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.